{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:48:52Z","timestamp":1785934132500,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To analyze the changes in antimicrobial resistance of\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (\n                      <jats:italic>S. aureus<\/jats:italic>\n                      ) and coagulase-negative staphylococci (CoNS) in bloodstream infections (BSIs) between 2018 and 2024, and to assess temporal associations with the COVID-19 pandemic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 575\n                      <jats:italic>S. aureus<\/jats:italic>\n                      and 1,014 CoNS isolates from blood cultures were retrospectively reviewed. To define true CoNS BSI, we applied clinical criteria (\u2265\u20092 positive bottles with same species, or 1 positive bottle with clinical signs\u2009+\u2009central line\u2009+\u2009targeted therapy). Demographic characteristics and resistance rates to 15 antimicrobial agents were compared using chi-square (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      ) and Mann-Kendall tests, with 95% confidence intervals (CIs) and Bonferroni correction for multiple comparisons.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CoNS infections were more common in minors (0\u201317 years: 31.3%) and the elderly (\u2265\u200980 years: 13.7%), while\n                      <jats:italic>S. aureus<\/jats:italic>\n                      predominated in adults 18\u201365 years (51.8%). CoNS exhibited higher resistance rates than\n                      <jats:italic>S. aureus<\/jats:italic>\n                      to oxacillin (75.2% vs. 30.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), ciprofloxacin (42.8% vs. 17.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and erythromycin (82.2% vs. 56.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Methicillin-resistant CoNS (MRCNS) detection rates exceeding 70% throughout. Penicillin G resistance in\n                      <jats:italic>S. aureus<\/jats:italic>\n                      increased from 87.1% (95% CI 78.0\u201393.0) in 2018 to 100% (95% CI 92.5\u2013100) in 2024 (nominal\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05, but not significant after correction). Following the pandemic onset, resistance rates to penicillin G, clindamycin, and ciprofloxacin further increased in both groups. After Bonferroni correction, the pandemic-period resistance rate increases of penicillin G, oxacillin, clindamycin, and erythromycin for\n                      <jats:italic>S. aureus<\/jats:italic>\n                      remained significant, while those for CoNS did not. No resistance to linezolid, vancomycin, or tigecycline was detected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Staphylococci resistance in blood isolates has intensified, with temporal associations observed during the Coronavirus Disease 2019 (COVID-19) pandemic. Clinicians should reconsider empirical oxacillin use given persistently high methicillin resistance. Ongoing surveillance and antimicrobial stewardship are essential. Causal attribution is not possible due to uncontrolled confounders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13949-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:45:54Z","timestamp":1783503954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in antimicrobial resistance of staphylococci isolated from bloodstream infection and the impact of COVID-19"],"prefix":"10.1186","volume":"26","author":[{"given":"Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"0140\u20136736","key":"13949_CR1","first-page":"0","volume":"0","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Stein DJ, Ikuta KS, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;0(0140\u20136736):0\u20130.","journal-title":"Lancet"},{"issue":"0140\u20136736","key":"13949_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(0140\u20136736):629\u201355.","journal-title":"Lancet"},{"issue":"1473\u20133099","key":"13949_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1473-3099(02)00438-3","volume":"2","author":"C Von Eiff","year":"2002","unstructured":"Von Eiff C, Peters G, Christine H. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis. 2002;2(1473\u20133099):677\u201385.","journal-title":"Lancet Infect Dis"},{"issue":"1740\u20131526","key":"13949_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"N Turner","year":"2019","unstructured":"Turner N, Kuinkel BKS, Maskarinec SA, Eichenberger EM, Shah P, Carugati M, Holland TL, Fowler VG. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17(1740\u20131526):203\u201318.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"13949_CR5","doi-asserted-by":"publisher","first-page":"2449085","DOI":"10.1080\/22221751.2024.2449085","volume":"14","author":"N Kaku","year":"2025","unstructured":"Kaku N, Ishige M, Yasutake G, et al. Long-term impact of molecular epidemiology shifts of methicillin-resistant Staphylococcus aureus on severity and mortality of bloodstream infection. Emerg Microbes Infect. 2025;14(1):2449085.","journal-title":"Emerg Microbes Infect"},{"issue":"10","key":"13949_CR6","first-page":"1111","volume":"24","author":"Y Yu","year":"2022","unstructured":"Yu Y, Dong Q, Hu J, Li W, Wang T, Yang Y, Gong X, He X, Chen P. A 10-year retrospective study of pathogens and antimicrobial resistance in neonatal sepsis. Zhongguo dang dai er ke za zhi\u2009=\u2009Chinese. J Contemp Pediatr. 2022;24(10):1111\u20136.","journal-title":"J Contemp Pediatr"},{"issue":"0002\u20138614","key":"13949_CR7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/jgs.15391","volume":"66","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Righi E, Giacomo PD, et al. Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults. J AM GERIATR SOC. 2018;66(0002\u20138614):1284\u20139.","journal-title":"J AM GERIATR SOC"},{"issue":"1471\u20132334","key":"13949_CR8","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1186\/s12879-023-08206-y","volume":"23","author":"K Hasmukharay","year":"2023","unstructured":"Hasmukharay K, Ngoi ST, Saedon NI, et al. Evaluation of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Epidemiology, clinical characteristics, and outcomes in the older patients in a tertiary teaching hospital in Malaysia. BMC INFECT DIS. 2023;23(1471\u20132334):0\u20130.","journal-title":"BMC INFECT DIS"},{"issue":"9","key":"13949_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.cmi.2018.11.012","volume":"25","author":"C Heilmann","year":"2019","unstructured":"Heilmann C, Ziebuhr W, Becker K. Are coagulase-negative staphylococci virulent? Clin Microbiol Infect. 2019;25(9):1071\u201380.","journal-title":"Clin Microbiol Infect"},{"key":"13949_CR10","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.3390\/microorganisms10061130","volume":"10","author":"HO Eltwisy","year":"2022","unstructured":"Eltwisy HO, Twisy HO, Hafez MH, Sayed IM, Mokhtar MAE. Clinical Infections, Antibiotic Resistance, and Pathogenesis of Staphylococcus haemolyticus. Microorganisms. 2022;10:2076\u2013607.","journal-title":"Microorganisms"},{"key":"13949_CR11","doi-asserted-by":"crossref","unstructured":"Bailey P, Doern CD. Evaluating the predictive value of blood culture bottle reporting for coagulase negative staphylococci-positive cultures: assessing contamination vs. true bacteremia. Open Forum Infect Dis. 2019;6(2328\u20138957):S105\u20136.","DOI":"10.1093\/ofid\/ofz360.236"},{"issue":"0021\u20139258","key":"13949_CR12","doi-asserted-by":"publisher","first-page":"40802","DOI":"10.1074\/jbc.M403589200","volume":"279","author":"C Fuda","year":"2004","unstructured":"Fuda C, Suvorov M, Vakulenko SB, Mobashery S. The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem. 2004;279(0021\u20139258):40802\u20136.","journal-title":"J Biol Chem"},{"issue":"0021\u20139193","key":"13949_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1128\/jb.158.2.513-516.1984","volume":"158","author":"BJ Hartman","year":"1984","unstructured":"Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J BACTERIOL. 1984;158(0021\u20139193):513\u20136.","journal-title":"J BACTERIOL"},{"issue":"0305\u20137453","key":"13949_CR14","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1093\/jac\/dku283","volume":"69","author":"V de Lastours","year":"2014","unstructured":"de Lastours V, Chau F, Roy C, Larroque B, Fantin B. Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone. J Antimicrob Chemother. 2014;69(0305\u20137453):3393\u2013400.","journal-title":"J Antimicrob Chemother"},{"issue":"0924\u20138579","key":"13949_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ijantimicag.2015.09.004","volume":"46","author":"AL Munier","year":"2015","unstructured":"Munier AL, de Lastours V, Barbier F, Chau F, Fantin B, Ruimy R. Comparative dynamics of the emergence of fluoroquinolone resistance in staphylococci from the nasal microbiota of patients treated with fluoroquinolones according to their environment. INT J ANTIMICROB AG. 2015;46(0924\u20138579):653\u20139.","journal-title":"INT J ANTIMICROB AG"},{"issue":"5","key":"13949_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/antibiotics10050527","volume":"10","author":"F Petrillo","year":"2021","unstructured":"Petrillo F, Pignataro D, Di Lella FM, et al. Antimicrobial Susceptibility Patterns and Resistance Trends of Staphylococcus aureus and Coagulase-Negative Staphylococci Strains Isolated from Ocular Infections. Antibiot (Basel). 2021;10(5):527.","journal-title":"Antibiot (Basel)"},{"issue":"2249\u20138176","key":"13949_CR17","first-page":"341","volume":"13","author":"S Jain","year":"2023","unstructured":"Jain S, Kumar R, Karicheri R. Antibiotic sensitivity pattern of coagulase negative staphylococci in a tertiary care hospital of Southern Rajasthan. Panacea J Med Sci. 2023;13(2249\u20138176):341\u20134.","journal-title":"Panacea J Med Sci"},{"issue":"2047\u20132994","key":"13949_CR18","first-page":"0","volume":"8","author":"J Cui","year":"2019","unstructured":"Cui J, Liang Z, Mo Z, Zhang J. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China. ANTIMICROB RESIST IN. 2019;8(2047\u20132994):0\u20130.","journal-title":"ANTIMICROB RESIST IN"},{"key":"13949_CR19","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Guerra BA, Gonz\u00e1lez-Lara MF, De-Le\u00f3n-Cividanes NA, et al. Antimicrobial resistance patterns and antibiotic use during hospital conversion in the COVID-19 pandemic. Antibiotics (Basel). 2021;10(2079\u20136382):182.","DOI":"10.3390\/antibiotics10020182"},{"key":"13949_CR20","doi-asserted-by":"crossref","unstructured":"Serra N, Di Carlo P, Andriolo M, et al. Staphylococcus aureus and coagulase-negative staphylococci from bloodstream infections: frequency of occurrence and antimicrobial resistance, 2018\u20132021. Life (Basel). 2023;13(2075\u20131729):1356.","DOI":"10.3390\/life13061356"},{"issue":"2079\u20136382","key":"13949_CR21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/antibiotics10080954","volume":"10","author":"V Saini","year":"2021","unstructured":"Saini V, Jain C, Singh N, Alsulimani A, Gupta C, Dar SA, Haque S, Das S. Paradigm Shift in Antimicrobial Resistance Pattern of Bacterial Isolates during the COVID-19 Pandemic. Antibiot (Basel). 2021;10(2079\u20136382):954.","journal-title":"Antibiot (Basel)"},{"issue":"2079\u20136382","key":"13949_CR22","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/antibiotics13100966","volume":"13","author":"AL Golli","year":"2024","unstructured":"Golli AL, Popa SG, Cara M, Stoica G, For\u021bofoiu D, Sto\u00efca M. Antibiotic Resistance Pattern of Pathogens Isolated from Pediatric Patients during and after the COVID-19 Pandemic. Antibiot (Basel). 2024;13(2079\u20136382):966.","journal-title":"Antibiot (Basel)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13949-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:27:40Z","timestamp":1785932860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13949-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13949"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13949-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8396245\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study to analyse routinely collected data was approved by the Ethics Committee Office of Mianyang Central Hospital, Mianyang City, Sichuan Province, China (Approval No. 2S202403146-01). The study adhered to the principles of the Helsinki Declaration. Since the data analyzed were anonymized and routinely collected, the Ethics Committee of Mianyang Central Hospital waived the requirement for informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to the submitted version of the manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1431"}}